Levels of Endothelial Nitric Oxide Synthase and Calcitonin Gene-related Peptide in the Charcot Foot: A Pilot Study

Javier La Fontaine, Lawrence B. Harkless, Victor L. Sylvia, David Carnes, Josefine Heim-Hall, Edward Jude

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The pathogenesis of Charcot neuroarthropathy is unclear. To investigate the possibility that decreased levels of calcitonin gene-related peptide and endothelial nitric oxide synthase are involved in the process, we studied bone samples from healthy subjects (n = 4), subjects with diabetic neuropathy (n = 4), and subjects with Charcot neuroarthropathy (n = 4). A statistically significant difference was found in endothelial nitric oxide synthase expression between bone specimens in patients with diabetic neuropathy, Charcot neuroarthropathy, and normal bone (P = .008). A trend toward calcitonin gene-related peptide intensification was observed in normal bone as compared to diabetic neuropathy and Charcot neuroarthropathy bone specimens, but it did not reached statistical significance (P = .23). This pilot study suggests that abnormal calcitonin gene-related peptide and endothelial nitric oxide synthase activity may play a role in the development of Charcot neuroarthropathy. Level of Clinical Evidence: 4.

Original languageEnglish (US)
Pages (from-to)424-429
Number of pages6
JournalJournal of Foot and Ankle Surgery
Volume47
Issue number5
DOIs
StatePublished - Sep 2008

Fingerprint

Calcitonin Gene-Related Peptide
Nitric Oxide Synthase Type III
Foot
Diabetic Neuropathies
Bone and Bones
Pyridinolcarbamate
Healthy Volunteers

Keywords

  • calcitonin
  • Charcot neuroarthropathy
  • diabetes
  • endothelial nitric oxide synthase
  • neuropathy

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Levels of Endothelial Nitric Oxide Synthase and Calcitonin Gene-related Peptide in the Charcot Foot : A Pilot Study. / La Fontaine, Javier; Harkless, Lawrence B.; Sylvia, Victor L.; Carnes, David; Heim-Hall, Josefine; Jude, Edward.

In: Journal of Foot and Ankle Surgery, Vol. 47, No. 5, 09.2008, p. 424-429.

Research output: Contribution to journalArticle

La Fontaine, Javier ; Harkless, Lawrence B. ; Sylvia, Victor L. ; Carnes, David ; Heim-Hall, Josefine ; Jude, Edward. / Levels of Endothelial Nitric Oxide Synthase and Calcitonin Gene-related Peptide in the Charcot Foot : A Pilot Study. In: Journal of Foot and Ankle Surgery. 2008 ; Vol. 47, No. 5. pp. 424-429.
@article{2b196d174de247b6b8d48ddd685a25c8,
title = "Levels of Endothelial Nitric Oxide Synthase and Calcitonin Gene-related Peptide in the Charcot Foot: A Pilot Study",
abstract = "The pathogenesis of Charcot neuroarthropathy is unclear. To investigate the possibility that decreased levels of calcitonin gene-related peptide and endothelial nitric oxide synthase are involved in the process, we studied bone samples from healthy subjects (n = 4), subjects with diabetic neuropathy (n = 4), and subjects with Charcot neuroarthropathy (n = 4). A statistically significant difference was found in endothelial nitric oxide synthase expression between bone specimens in patients with diabetic neuropathy, Charcot neuroarthropathy, and normal bone (P = .008). A trend toward calcitonin gene-related peptide intensification was observed in normal bone as compared to diabetic neuropathy and Charcot neuroarthropathy bone specimens, but it did not reached statistical significance (P = .23). This pilot study suggests that abnormal calcitonin gene-related peptide and endothelial nitric oxide synthase activity may play a role in the development of Charcot neuroarthropathy. Level of Clinical Evidence: 4.",
keywords = "calcitonin, Charcot neuroarthropathy, diabetes, endothelial nitric oxide synthase, neuropathy",
author = "{La Fontaine}, Javier and Harkless, {Lawrence B.} and Sylvia, {Victor L.} and David Carnes and Josefine Heim-Hall and Edward Jude",
year = "2008",
month = "9",
doi = "10.1053/j.jfas.2008.05.009",
language = "English (US)",
volume = "47",
pages = "424--429",
journal = "Journal of Foot and Ankle Surgery",
issn = "1067-2516",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Levels of Endothelial Nitric Oxide Synthase and Calcitonin Gene-related Peptide in the Charcot Foot

T2 - A Pilot Study

AU - La Fontaine, Javier

AU - Harkless, Lawrence B.

AU - Sylvia, Victor L.

AU - Carnes, David

AU - Heim-Hall, Josefine

AU - Jude, Edward

PY - 2008/9

Y1 - 2008/9

N2 - The pathogenesis of Charcot neuroarthropathy is unclear. To investigate the possibility that decreased levels of calcitonin gene-related peptide and endothelial nitric oxide synthase are involved in the process, we studied bone samples from healthy subjects (n = 4), subjects with diabetic neuropathy (n = 4), and subjects with Charcot neuroarthropathy (n = 4). A statistically significant difference was found in endothelial nitric oxide synthase expression between bone specimens in patients with diabetic neuropathy, Charcot neuroarthropathy, and normal bone (P = .008). A trend toward calcitonin gene-related peptide intensification was observed in normal bone as compared to diabetic neuropathy and Charcot neuroarthropathy bone specimens, but it did not reached statistical significance (P = .23). This pilot study suggests that abnormal calcitonin gene-related peptide and endothelial nitric oxide synthase activity may play a role in the development of Charcot neuroarthropathy. Level of Clinical Evidence: 4.

AB - The pathogenesis of Charcot neuroarthropathy is unclear. To investigate the possibility that decreased levels of calcitonin gene-related peptide and endothelial nitric oxide synthase are involved in the process, we studied bone samples from healthy subjects (n = 4), subjects with diabetic neuropathy (n = 4), and subjects with Charcot neuroarthropathy (n = 4). A statistically significant difference was found in endothelial nitric oxide synthase expression between bone specimens in patients with diabetic neuropathy, Charcot neuroarthropathy, and normal bone (P = .008). A trend toward calcitonin gene-related peptide intensification was observed in normal bone as compared to diabetic neuropathy and Charcot neuroarthropathy bone specimens, but it did not reached statistical significance (P = .23). This pilot study suggests that abnormal calcitonin gene-related peptide and endothelial nitric oxide synthase activity may play a role in the development of Charcot neuroarthropathy. Level of Clinical Evidence: 4.

KW - calcitonin

KW - Charcot neuroarthropathy

KW - diabetes

KW - endothelial nitric oxide synthase

KW - neuropathy

UR - http://www.scopus.com/inward/record.url?scp=49849101514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49849101514&partnerID=8YFLogxK

U2 - 10.1053/j.jfas.2008.05.009

DO - 10.1053/j.jfas.2008.05.009

M3 - Article

C2 - 18725122

AN - SCOPUS:49849101514

VL - 47

SP - 424

EP - 429

JO - Journal of Foot and Ankle Surgery

JF - Journal of Foot and Ankle Surgery

SN - 1067-2516

IS - 5

ER -